Anastasia Iatrou, Maria Gounari, Electra Sofou, Laura Zaragoza-Infante, Ioannis Markopoulos, Ioannis Sarrigeorgiou, Georgios Petrakis, Nikolaos Pechlivanis, Maria Roumeliotou-Dimou, Panagiotis Panayiotidis, Basile Stamatopoulos, Maria Gkanidou, Rafael Sandaltzopoulos, Massimo Degano, Triantafyllia Koletsa, Peggy Lymberi, Fotis Psomopoulos, Paolo Ghia, Andreas Agathangelidis, Anastasia Chatzidimitriou, Kostas Stamatopoulos
Subset #201 is a clinically indolent subgroup of patients with chronic lymphocytic leukemia defined by the expression of stereotyped, mutated IGHV4-34/IGLV1-44 BCR Ig. Subset #201 is characterized by recurrent somatic hypermutations (SHMs) that frequently lead to the creation and/or disruption of N-glycosylation sites within the Ig H and L chain variable domains. To understand the relevance of this observation, using next-generation sequencing, we studied how SHM shapes the subclonal architecture of the BCR Ig repertoire in subset #201, particularly focusing on changes in N-glycosylation sites...
July 19, 2023: Journal of Immunology